These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 18163993)

  • 1. Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome.
    Moran C; Renteria JL; Moran S; Herrera J; Gonzalez S; Bermudez JA
    Fertil Steril; 2008 Dec; 90(6):2310-7. PubMed ID: 18163993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
    Liou TH; Yang JH; Hsieh CH; Lee CY; Hsu CS; Hsu MI
    Fertil Steril; 2009 Dec; 92(6):1960-5. PubMed ID: 18980763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome.
    Ludwig AK; Goharian LG; Dietze T; Tauchert S; Rudolf S; Diedrich K; Schweiger U; Oltmanns KM
    Fertil Steril; 2009 Jul; 92(1):271-6. PubMed ID: 18692843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACTH stimulation test in lean polycystic ovary syndrome patients with insulin resistance.
    Uncu G; Ozyurek SE; Uncu Y
    Fertil Steril; 2007 Sep; 88(3):670-4. PubMed ID: 17451692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum retinol-binding protein 4 levels in nonobese women with polycystic ovary syndrome.
    Chan TF; Tsai YC; Chiu PR; Chen YL; Lee CH; Tsai EM
    Fertil Steril; 2010 Feb; 93(3):869-73. PubMed ID: 19028383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin.
    Guido M; Romualdi D; De Marinis L; Porcelli T; Giuliani M; Costantini B; Lanzone A
    Fertil Steril; 2007 Jul; 88(1):125-30. PubMed ID: 17276431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
    Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.
    Maciel GA; Soares Júnior JM; Alves da Motta EL; Abi Haidar M; de Lima GR; Baracat EC
    Fertil Steril; 2004 Feb; 81(2):355-60. PubMed ID: 14967373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases].
    Hu WH; Qiao J; Li MZ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(11):721-4. PubMed ID: 17565837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired growth hormone secretion after glucose loading in non-obese women with polycystic ovary syndrome, possibly related to androgen but not insulin and free fatty acids.
    Takeuchi T; Tsutsumi O; Taketani Y
    Gynecol Endocrinol; 2007; 23(8):468-73. PubMed ID: 17852425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of hormonal response to the GnRH agonist leuprolide in brothers of women with polycystic ovary syndrome: a pilot study.
    Petermann TS; Cartes A; Maliqueo M; Vantman D; Gutiérrez C; Toloza H; Echiburú B; Recabarren SE
    Hum Reprod; 2004 Dec; 19(12):2742-7. PubMed ID: 15358722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
    Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome.
    Nafiye Y; Sevtap K; Muammer D; Emre O; Senol K; Leyla M
    Fertil Steril; 2010 Apr; 93(6):1864-9. PubMed ID: 19171332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin resistance in obese and non-obese patients with polycystic ovary syndrome. Possible role in the pathogenesis of the disease].
    Vagiri D; Barletta C; Cioli I; Scavo D
    Minerva Endocrinol; 1994 Mar; 19(1):5-12. PubMed ID: 8035770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucose and lipid metabolism in patients with polycystic ovary syndrome].
    Ge XL; Lou SZ; Shen HM
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):527-30, 573. PubMed ID: 7835128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.